BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9893995)

  • 1. Carboxy-terminal processing of the urokinase receptor: implications for substrate recognition and glycosylphosphatidylinositol anchor addition.
    Aceto J; Kieber-Emmons T; Cines DB
    Biochemistry; 1999 Jan; 38(3):992-1001. PubMed ID: 9893995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of the carboxyl-terminal signal for GPI modification requires translocation of its hydrophobic domain across the ER membrane.
    Wang J; Maziarz K; Ratnam M
    J Mol Biol; 1999 Mar; 286(5):1303-10. PubMed ID: 10064698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
    Vines DJ; Lee SW; Dichek DA; Ellis V
    J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proprotein interaction with the GPI transamidase.
    Chen R; Anderson V; Hiroi Y; Medof ME
    J Cell Biochem; 2003 Apr; 88(5):1025-37. PubMed ID: 12616539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hydrophobic domains in the carboxyl-terminal signal for GPI modification and in the amino-terminal leader peptide have similar structural requirements.
    Yan W; Shen F; Dillon B; Ratnam M
    J Mol Biol; 1998 Jan; 275(1):25-33. PubMed ID: 9451436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site.
    Ploug M
    Biochemistry; 1998 Nov; 37(47):16494-505. PubMed ID: 9843416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular glycosylphosphatidylinositol-specific phospholipase D regulates urokinase receptor shedding and cell surface expression.
    Wilhelm OG; Wilhelm S; Escott GM; Lutz V; Magdolen V; Schmitt M; Rifkin DB; Wilson EL; Graeff H; Brunner G
    J Cell Physiol; 1999 Aug; 180(2):225-35. PubMed ID: 10395292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor.
    Høyer-Hansen G; Pessara U; Holm A; Pass J; Weidle U; Danø K; Behrendt N
    Biochem J; 2001 Sep; 358(Pt 3):673-9. PubMed ID: 11535128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatidylinositol glycan (PI-G) anchored membrane proteins. Amino acid requirements adjacent to the site of cleavage and PI-G attachment in the COOH-terminal signal peptide.
    Gerber LD; Kodukula K; Udenfriend S
    J Biol Chem; 1992 Jun; 267(17):12168-73. PubMed ID: 1601882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analysis and tissue localization of human C4.4A: a protein homologue of the urokinase receptor.
    Hansen LV; Gårdsvoll H; Nielsen BS; Lund LR; Danø K; Jensen ON; Ploug M
    Biochem J; 2004 Jun; 380(Pt 3):845-57. PubMed ID: 15012588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficiencies of C-terminal signals of native glycophosphatidylinositol (GPI)-anchored proproteins in conferring GPI-anchoring.
    Chen R; Knez JJ; Merrick WC; Medof ME
    J Cell Biochem; 2001; 84(1):68-83. PubMed ID: 11746517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COOH-terminal processing of nascent polypeptides by the glycosylphosphatidylinositol transamidase in the presence of hydrazine is governed by the same parameters as glycosylphosphatidylinositol addition.
    Ramalingam S; Maxwell SE; Medof ME; Chen R; Gerber LD; Udenfriend S
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7528-33. PubMed ID: 8755508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosynthesis of glycosylphosphatidylinositol (GPI)-anchored membrane proteins in intact cells: specific amino acid requirements adjacent to the site of cleavage and GPI attachment.
    Kodukula K; Gerber LD; Amthauer R; Brink L; Udenfriend S
    J Cell Biol; 1993 Feb; 120(3):657-64. PubMed ID: 8425894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolysis of the carboxyl-terminal GPI signal independent of GPI modification as a mechanism for selective protein secretion.
    Wang J; Shen F; Yan W; Wu M; Ratnam M
    Biochemistry; 1997 Nov; 36(47):14583-92. PubMed ID: 9398177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of urokinase plasminogen activator to gp130 via a putative urokinase-binding consensus sequence.
    Liang OD; Chavakis T; Linder M; Bdeir K; Kuo A; Preissner KT
    Biol Chem; 2003 Feb; 384(2):229-36. PubMed ID: 12675515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unesterified long chain fatty acids inhibit the binding of single chain urokinase to the urokinase receptor.
    al-Roof Higazi A; Aceto JF; Kniss D; Upson R; Cohen R; Dichek DA; Cines DB
    Biochemistry; 1996 May; 35(21):6884-90. PubMed ID: 8639640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage without anchor addition accompanies the processing of a nascent protein to its glycosylphosphatidylinositol-anchored form.
    Maxwell SE; Ramalingam S; Gerber LD; Udenfriend S
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1550-4. PubMed ID: 7878018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of the GPI pre-anchor sequence in human p97--a general approach for generating the soluble form of GPI-linked proteins.
    Yang J; Tiong J; Kennard M; Jefferies WA
    Protein Expr Purif; 2004 Mar; 34(1):28-48. PubMed ID: 14766298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex virus 1 recombinant virions exhibiting the amino terminal fragment of urokinase-type plasminogen activator can enter cells via the cognate receptor.
    Kamiyama H; Zhou G; Roizman B
    Gene Ther; 2006 Apr; 13(7):621-9. PubMed ID: 16292350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87).
    Magdolen V; Bürgle M; de Prada NA; Schmiedeberg N; Riemer C; Schroeck F; Kellermann J; Degitz K; Wilhelm OG; Schmitt M; Kessler H
    Biol Chem; 2001 Aug; 382(8):1197-205. PubMed ID: 11592401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.